{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:40:49Z","timestamp":1792683649426,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003648","name":"National Medical Center","doi-asserted-by":"publisher","award":["NMC_I_2023_019"],"award-info":[{"award-number":["NMC_I_2023_019"]}],"id":[{"id":"10.13039\/501100003648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["0320230370"],"award-info":[{"award-number":["0320230370"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["3020240070"],"award-info":[{"award-number":["3020240070"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijid.2026.109100","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:46:30Z","timestamp":1788882390000},"page":"109100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of CD4 T cell counts on the immunogenicity and safety of the recombinant zoster vaccine in people living with HIV"],"prefix":"10.1016","volume":"172","author":[{"given":"Min-Kyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jae","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Kyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Eunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Sang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyoeng Gyun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonjae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BumSik","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-9625","authenticated-orcid":false,"given":"Wan Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109100_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.ijid.2026.109100_bib0002","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/aid.2010.0340","article-title":"Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults","volume":"27","author":"De Castro","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"10.1016\/j.ijid.2026.109100_bib0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1086\/422011","article-title":"Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy","volume":"190","author":"Weinberg","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.109100_bib0004","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.109100_bib0005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/cid\/ciu1161","article-title":"Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort","volume":"60","author":"Grabar","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.109100_bib0006","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3947\/ic.2023.0045","article-title":"Assessment of disease burden and immunization rates for vaccine-preventable diseases in people living with HIV: the Korea HIV\/AIDS cohort study","volume":"55","author":"Seong","year":"2023","journal-title":"Infect Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2026.109100_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.qai.0000178408.62675.b0","article-title":"The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2026.109100_bib0008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fpubh.2018.00070","article-title":"Herpes zoster in persons living with HIV-1 infection: viremia and immunological defects are strong risk factors in the era of combination antiretroviral therapy","volume":"6","author":"Erdmann","year":"2018","journal-title":"Front Public Health"},{"issue":"22","key":"10.1016\/j.ijid.2026.109100_bib0009","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijid.2026.109100_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.ijid.2026.109100_bib0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ijid.2026.109100_bib0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ijid.2026.109100_bib0013","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised clinical trial and post-hoc efficacy analysis","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.109100_bib0014","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/cncr.31909","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors vaccinated before or during chemotherapy: a randomized trial","volume":"125","author":"Vink","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijid.2026.109100_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3 randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.109100_bib0016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.109100_bib0017","unstructured":"Department of Health and Human Services. DHHS guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/immunizations?view=full. [Accessed July 22, 2025]."},{"issue":"11","key":"10.1016\/j.ijid.2026.109100_bib0018","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.109100_bib0019","series-title":"Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials","year":"2007"},{"key":"10.1016\/j.ijid.2026.109100_bib0020","doi-asserted-by":"crossref","DOI":"10.3947\/ic.2025.0036","article-title":"Post-marketing surveillance of a live attenuated herpes zoster vaccine (SKYZoster\u00ae) in adults aged \u226550 years in Korea","volume":"57","author":"Baik","year":"2025","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijid.2026.109100_bib0021","unstructured":"Statistics Kingdom. Proportion confidence interval calculator. Available from: https:\/\/www.statskingdom.com\/proportion-confidence-interval-calculator.html. [Accessed 15 June 2025]."},{"issue":"11","key":"10.1016\/j.ijid.2026.109100_bib0022","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/cid\/ciy242","article-title":"Safety and immunogenicity of zoster vaccine live in HIV-infected adults with CD4+ cell counts >200 cells\/mL virologically suppressed on antiretroviral therapy","volume":"67","author":"Benson","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.109100_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(24)00084-5","article-title":"Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial","volume":"6","author":"Park","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.ijid.2026.109100_bib0024","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40264-021-01076-w","article-title":"Safety profile of the adjuvanted recombinant zoster vaccine in immunocompromised populations: an overview of six trials","volume":"44","author":"L\u00f3pez-Fauqued","year":"2021","journal-title":"Drug Saf"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:52:11Z","timestamp":1792680731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226007356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"alternative-id":["S1201971226007356"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109100","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of CD4 T cell counts on the immunogenicity and safety of the recombinant zoster vaccine in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109100"}}